Description
Comprehensive immunohistochemical study of endometrial receptor status (expression of natural killers (CD56), plasma cells (CD138), monoclonal antibodies to progesterone and estrogen (PR, ER), and polyclonal antibodies to leukemia inhibitory factor (LIF)), allowing assessment of its functional activity, which is necessary to decide on the implementation and volume of drug correction.
It is prescribed only in the presence of a prepared histological specimen and a histological conclusion.
Strict correspondence of the cycle phase/stage to this study is required.
Period of execution
Within 8 days
Biomaterial type
- Tissue sample
- Tissue sample in paraffin block